OOIR: Observatory of International Research

Papers

(The TQCC of Journal of Alzheimers Disease is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Individual electric field in cortical white matter is correlated with cognitive improvement in patients with mild cognitive impairment due to Alzheimer's disease after repetitive transcranial magnetic	163
p53 SUMOylation promotes neurogenesis defects in APP/PS1 mice	112
Hydrate to keep the amyloid away	98
Under-Diagnosis of Dementia with Lewy Bodies in Individuals Racialized as Black: Hypotheses Regarding Potential Contributors	91
Neurophysiological Alterations of the Visual Pathway in Posterior Cortical Atrophy: Systematic Review and a Case Series	82
Unraveling the impact of risk factors on the ferroptosis-Alzheimer's disease link for early detection	78
Soda consumption and risk of dementia: The Northern Manhattan study	76
Diagnostic accuracy of Alzheimer's Questionnaire in identifying dementia among Filipinos in a tertiary hospital	71
Mediation effect of neuropsychological factors on the relationship between social networks and mild cognitive impairment in older adults	70
Novel predictors of Alzheimer's disease in Down syndrome identified using machine learning	68
Corrigendum to “Leucettinib-21, a DYRK1A Kinase Inhibitor as Clinical Drug Candidate for Alzheimer's Disease and Down Syndrome”	67
Blood pressure dynamic instability and neurodegeneration in older adults	65
Patterns of cortical atrophy are associated with specific cognitive domains in patients with logopenic primary progressive aphasia	64
Discovering potential ERK1 inhibitors from natural products for therapeutic targeting of Alzheimer's disease	59
Exploring the potential of acupuncture as a complementary treatment for Alzheimer's disease: Pushing the boundaries forward	58
Late Midlife Subclinical Infarct Burden and Risk of Dementia: The Atherosclerosis Risk in Communities Neurocognitive Study	55
Sex-Related Differences in the Association Between Body Mass Index and Dementia Risk	54
Common Molecular Signatures Between Coronavirus Infection and Alzheimer’s Disease Reveal Targets for Drug Development	54
Alzheimer’s Disease Pathology Outside of the Cerebrum Is Related to a Higher Odds of Dementia	50
Slovenian Memory Clinic Organization with the Introduction of Potential New Alzheimer’s Disease Treatment	50
Cognitive Impairment and Associated Factors Among Adults with Type 2 Diabetes Mellitus in Bahir Dar City Referral Hospitals, 2021: Cross-Sectional Study	49
Fatty Acid-Binding Protein 3 Is a Marker of Neurodegeneration and White Matter Hyperintensity Burden in Mexican American Older Adults	48
Associations of the Harvard Automated Phone Task and Alzheimer’s Disease Pathology in Cognitively Normal Older Adults: Preliminary Findings	48
Associations Between Midlife Menopausal Hormone Therapy Use, Incident Diabetes, and Late Life Memory in the Wisconsin Longitudinal Study	48
Case Identification and Characterization of Migrants with Dementia in the Lazio Region Using Health Administrative Data	46

Targeting GluR3 in Depression and Alzheimer’s Disease: Novel Compounds and Therapeutic Prospects	45
Chain Mediation Analysis of the Effects of Nutrition and Cognition on the Association of Apolipoprotein E ɛ4 with Neuropsychiatric Symptoms in Alzheimer’s Disease	44
Spatial differences in gene expression across the dorsal raphe nucleus in a model of early Alzheimer's disease	44
In-silico Codon Context and Synonymous Usage Analysis of Genes for Molecular Mechanisms Inducing Autophagy and Apoptosis with Reference to Neurodegenerative Disorders	42
Remnant cholesterol and cognitive function: Evidence from the China health and retirement longitudinal study	41
Uncovering the Oxidative Stress Mechanisms and Targets in Alzheimer’s Disease by Integrating Phenotypic Screening Data and Polypharmacology Networks	41
CMS121, a Novel Drug Candidate for the Treatment of Alzheimer’s Disease and Age-Related Dementia	39
Neurovascular Correlates of Cobalamin, Folate, and Homocysteine in Dementia	39
Physical Activity in Mild Vascular Cognitive Impairment: Results of the AFIVASC Randomized Controlled Trial at 6 Months	39
Education attainment and nutritional status in the prevention of cognitive impairment in the hospitalized Chinese elderly	39
Low Serum Insulin-like Growth Factor-I Is Associated with Decline in Hippocampal Volume in Stable Mild Cognitive Impairment but not in Alzheimer’s Disease	38
Characterization of Early Alzheimer’s Disease-Like Pathological Alterations in Non-Human Primates with Aging: A Pilot Study	38
Alzheimer’s Disease with Epileptiform EEG Activity: Abnormal Cortical Sources of Resting State Delta Rhythms in Patients with Amnesic Mild Cognitive Impairment	38
Sexual dimorphism, altered hippocampal glutamatergic neurotransmission, and cognitive impairment in APP knock-in mice	37
Needs of people living with young-onset dementia and family carers, explored by dementia subtype, phase in the disease process, and living setting: A scoping review	37
Prescription-based association of P-glycoprotein substrates with Alzheimer's disease risk: A nested case-control study	37
Disruptions of deep medullary veins and MRI indices of glymphatic function in cerebral small vessel disease	37
Autoantibodies in Alzheimer's disease: Multifaceted roles and therapeutic horizons	37
Efficacy of Souvenaid® Combined with Acetylcholinesterase Inhibitors in the Treatment of Mild Alzheimer’s Disease	36
A multi-modal and multi-stage region of interest-based fusion network convolutional neural network model to differentiate progressive mild cognitive impairment from stable mild cognitive impairment	36
Gene Association Study of the Urokinase Plasminogen Activator and Its Receptor Gene in Alzheimer’s Disease	36
Decoding the key mechanisms of ferroptosis and inflammation: Emerging therapeutic targets for Alzheimer's disease	35
Reduction in Constitutively Activated Auditory Brainstem Microglia in Aging and Alzheimer’s Disease	35
Mortality Risks and Causes of Death by Dementia Types in a Japanese Cohort with Dementia: NCGG-STORIES	35
Neural Computation-Based Methods for the Early Diagnosis and Prognosis of Alzheimer’s Disease Not Using Neuroimaging Biomarkers: A Systematic Review	34
Dementia in Denmark: Uncovering the causes of death and life years lost in a nationwide, register-based cohort study	34
Peripheral blood immune cell phenotypes and Alzheimer’s disease: A mediation Mendelian randomization study	34
One of the binding proteins for administered amyloid-β appears to be anti-Aβ IgG antibody in amyloid plaques	34
Early CA2 Tau Inclusions Do Not Distinguish an Age-Related Tauopathy from Early Alzheimer’s Disease	34
Multimorbidity, Social Engagement, and Age-Related Cognitive Decline in Older Adults from the Rancho Bernardo Study of Healthy Aging	34
Regional gyrification alterations and metabolic correlates in biologically defined Alzheimer's disease using a multimodal approach	34
Hypertensive Aspects of Cardiometabolic Disorders Are Associated with Lower Brain Microstructure, Perfusion, and Cognition	33
Auditory Event-Related Potentials in Older Adults with Subjective Memory Complaints	33
Vaccines and Dementia: Part II. Efficacy of BCG and Other Vaccines Against Dementia	33
Postmortem tau in the CA2 region of the hippocampus in older adult men who participated in youth amateur American-style football	32
Incident Dementia After Spontaneous Intracerebral Hemorrhage	32
Multi-Site Cross-Site Inter-Rater and Test-Retest Reliability and Construct Validity of the MarkVCID White Matter Hyperintensity Growth and Regression Protocol	31
Integrated amyloid, neurodegeneration, and vascular biomarkers estimate the risk of dementia progression in mild cognitive impairment	31
Subjective Cognitive Decline Is Associated with Health-Related Quality of Life in the Middle-Aged to Elderly Population	31
Search in the Periphery for Potential Inflammatory Biomarkers of Dementia with Lewy Bodies and Alzheimer’s Disease	31
The CERAD Word List Memory Test: Normative Data Based on a Norwegian Population-Based Sample of Healthy Older Adults 70 Years and Above. The HUNT Study	30
Taxifolin for Cognitive Preservation in Patients with Mild Cognitive Impairment or Mild Dementia	30
Understanding of Dementia in the Polish Language: A Frame Semantic Approach	29
Correlation Between Amyloid PET Imaging and Discordant Cerebrospinal Fluid Biomarkers Results in Patients with Suspected Alzheimer’s Disease	29
Multilayer brain connectivity and long-term cognitive changes in individuals at risk for Alzheimer's disease	29
The association between hemoglobin level and risk of developing dementia	28
Attentional Control in Subjective Cognitive Decline	28
Relationship periodontitis and Alzheimer's disease: Relevant aspects from an epigenetic view	28
Comparison of visit-to-visit blood pressure variability and time in target range in predicting risk for cognitive outcomes in the SPRINT trial	28
The Predictive Ability of Blood Neurofilament Light Chain in Predicting Cognitive Decline in the Alzheimer’s Disease Continuum: A Systematic Review and Meta-Analysis	28

Impacts of adapted dance on mood and physical function among persons living with Alzheimer's disease	28
Designing Newer Omega-3 Supplementation Trials for Cognitive Outcomes: A Systematic Review Guided Analysis	28
Vitamin D, a Secosteroid Hormone and Its Multifunctional Receptor, Vitamin D Receptor, in Alzheimer’s Type Neurodegeneration	28
Relationship Between Endothelial Function, Vital Parameters, and Cognitive Performance in Community Dwellers with Subjective Cognitive Decline: An Observational Study with Six Months Follow Up	28
Cerebrospinal fluid acetylcholine is not a reliable diagnostic marker for Alzheimer's disease and dementia with Lewy bodies	28
Fall Risk, Sleep Behavior, and Sleep-Related Movement Disorders in Young Urbanites Exposed to Air Pollution	27
A comparison of the Quick Dementia Rating System and Montreal Cognitive Assessment for detecting mild cognitive impairment and dementia assessed by the Clinical Dementia Rating Scale	27
Association Between Carotid Plaque and Alzheimer’s Disease Cerebrospinal Fluid Biomarkers and Cognitive Function in Cognitively Intact Adults: The CABLE Study	27
HARMONISATION – A multimodal prospective study of vascular cognitive impairment in multi-ethnic Asians: Cohort profile, progress, current contributions, and future impact	27
Improved Prediction of Amyloid-β and Tau Burden Using Hippocampal Surface Multivariate Morphometry Statistics and Sparse Coding	27
IL-34/TREM2 modulates microglia-mediated inflammation and provides neuroprotection in a mouse model of sporadic Alzheimer's disease	26
Decreased Hemodynamic Responses in Left Parietal Lobule and Left Inferior Parietal Lobule in Older Adults with Mild Cognitive Impairment: A Near-Infrared Spectroscopy Study	26
From autopsy to PET to cerebrospinal fluid to blood: Quantifying reference-standard dependence in Alzheimer's disease amyloid biomarker validation	26
Hospitalizations and long-term care for older adults with Alzheimer's disease and related dementia: Differences across geographic regions of the United States	26
Sex-specific accelerated epigenetic aging in the Alzheimer's disease spectrum	26
Effects of Melissa officinalis Extract Containing Rosmarinic Acid on Cognition in Older Adults Without Dementia: A Randomized Controlled Trial	26
Multicomponent exercise interventions for older adults with Alzheimer's disease: A systematic review and meta-analytical perspective	26
Altered temporal dynamics of intrinsic brain activity in mild cognitive impairment with olfactory dysfunction	26
Uncovering pathology, subjective cognitive complaints, and sex in early Alzheimer's disease	26
Choroid plexus–glymphatic axis disruption in Alzheimer's disease: Cerebrospinal fluid expansion as a mediator of metabolic dysfunction and cognitive decline	25
Serum Uric Acid Levels in Neurodegenerative Disorders: A Cross-Sectional Study	25
Effects of Exercise on Urinary AD7c-NTP (Alzheimer-Associated Neuronal Thread Protein) Levels and Cognitive Function Among Active Korean Elderly: A Randomized Controlled Trial	25
Sleep disturbances and language function impairment in the elderly: Evidence of limbic and prefrontal tracts involvement	25
Putting the Brakes on Accelerated Cognitive Decline in Alzheimer’s Disease with Epileptic Activity	25
Japan-multimodal intervention trial for the prevention of dementia in older people with lifestyle-related diseases: A community-based, 18-month, randomized controlled trial	25
Association of Anemia with Cognitive Function and Dementia Among Older Adults: The Role of Inflammation	25
The association between dual sensory impairment and dementia: A systematic review and meta-analysis	25
FTIR Spectroscopy and Blood-Derived Extracellular Vesicles Duo in Alzheimer’s Disease	25
Assessing Longitudinal Cognitive Change in Mild Cognitive Impairment Using Estimated Standardized Regression-Based Formulas	25
Prevalence and Factors Associated with Subjective Memory Complaint in a Semi-Rural Community in Chile	24
Is Carer Management Style Associated with Longitudinal Functional Decline in Dementia?	24
go4cognition: Combined Physiological and Cognitive Intervention in Mild Cognitive Impairment	24
Multifactorial Causation of Alzheimer’s Disease Due to COVID-19	24
Getting Insight to the Lived Emotional Experience of People with Alzheimer’s Disease Shortly After Diagnosis: A Phenomenological Approach	24
Baseline Frontoparietal Gray Matter Volume Predicts Executive Function Performance in Aging and Mild Cognitive Impairment at 24-Month Follow-Up	24
Code-Based Algorithms for Identifying Dementia in Electronic Health Records: Bridging the Gap Between Theory and Practice	24
Clinical Quality Indicators for Monitoring Hospitalizations Among Older People with Dementia Accessing Aged Care Services	24
Exploring the Genetic Heterogeneity of Alzheimer’s Disease: Evidence for Genetic Subtypes	24
Dynamic PET imaging in patients with unilateral carotid occlusion shows lateralized cerebral hypoperfusion, but no amyloid binding	23
Acute cerebral blood flow response to heavy cream ingestion in older adults: A non-randomized pilot study	23
Associations of Leisure Activities and Sleep Duration with Cognitive Function: A Nationwide Prospective Cohort Study of Chinese Old Adults	23
Sex Modifies the Associations of APOE ɛ4 with Neuropsychiatric Symptom Burden in Both At-Risk and Clinical Cohorts of Alzheimer’s Disease	23
Antidepressant and anxiolytic medications and risk of mortality in people with dementia: A nested case-control study in Northern Ireland	23
Posterior cortical atrophy in the age of anti-amyloid treatments: An 11-year retrospective study of eligible patients from the Leenaards Memory Center	23
Association of Kidney Function with Risk of Incident Dementia: A Prospective Cohort Study of 275,167 UK Biobank Participants	23
Evaluation of early-phase ¹⁸ F-Florbetaben PET as a surrogate biomarker of neurodegeneration: In-depth comparison with ¹⁸	23
Relationship Between Non-Cognitive Intrinsic Capacity and Activities of Daily Living According to Alzheimer’s Disease Stage	23
Distinct brain atrophy patterns in Lewy body disease: The impact and interaction of comorbid neuropathologies revealed by voxel-based morphometry	23
Associations of dietary protein and amino acid intakes with disability-adjusted life years for Alzheimer's disease in Japanese people	22
Impact of coronary interventions on dementia diagnosis by race: Insights from a multi-hospital heart-brain registry	22
COVID-19 and Alzheimer’s Disease: What Is the Connection?	22
Associations Between TREML2 Gene Variants and Alzheimer’s Disease: Biomarkers, Neuroimage, and Cognition	22
Mites, microbes, and neurodegeneration: A unified environmental hypothesis for Parkinson's disease, Alzheimer's disease, and Lewy body dementia	22
Cerebral Small Vessel Disease Burden Predicts Neurodegeneration and Clinical Progression in Prodromal Alzheimer’s Disease	22
Depression and Agitation Factors Are Related to Regional Brain Atrophy and Faster Longitudinal Cognitive Decline in Mild Cognitive Impairment	22
Neutrophil percentage-to-albumin ratio is associated with cognitive function in adults aged over 60 years: An analysis of data from the NHANES 2011–2014	22
Phosphorylated peptide Tau-pT181 induced tau aggregation and cognitive dysfunction	22
Evaluating MRI correlates of lifestyle-based dementia risk reduction: Results from the AgeWell.de imaging study	22
Impact of Cognitive Demand on Eye Movement Pattern in Patients with Alzheimer’s Disease	22
The role of carotenoids from red mamey fruit ( Pouteria sapota ) against amyloid-β monomers in Alzheimer's disease: Computational analysis and ADMET pred	22
Timing of neurorehabilitation and subsequent Alzheimer's disease risk in patients with moderate to severe traumatic brain injury: A nationwide retrospective cohort study in the United States	22
Perceived everyday discrimination and its effect on cognitive function through depression in diverse populations: A HABS-HD study	21
The Role of Interferon- α in Neurodegenerative Diseases: A Systematic Review	21
Association of Basal Forebrain Volume with Amyloid, Tau, and Cognition in Alzheimer’s Disease	21
Predictors of MRI-estimated brain iron deposition in dementia and Parkinson's disease-associated subcortical regions: Genetic and observational analysis in UK Biobank	21
Lucidity in deeply forgetful people: A national U.S. survey of caregivers’ reactions	21
Neural flexibility is higher in Alzheimer's disease and predicts Alzheimer's disease transition	21
Citicoline: A Cholinergic Precursor with a Pivotal Role in Dementia and Alzheimer’s Disease	21
Integrating kidney function assessment into the clinical interpretation of plasma Alzheimer's disease biomarkers	21
Treating Alzheimer’s Disease: Focusing on Neurodegenerative Consequences	21
Cyrus A. Raji, MD, PhD, is the recipient of the 2025 Mark A. Smith Alzheimer Award	21
Recent Advances in Drug Delivery Systems Targeting Insulin Signalling for the Treatment of Alzheimer’s Disease	21
Neural Stem Cells in the Treatment of Alzheimer’s Disease: Current Status, Challenges, and Future Prospects	21
Non-Modifiable Factors as Moderators of the Relationship Between Physical Activity and Brain Volume: A Cross-Sectional UK Biobank Study	21
Distinct patterns of microstructural brain changes in Alzheimer's disease subtypes: Diffusion MRI metrics in braak stage-related regions	21
Characterizing structure-function coupling in subjective memory complaints of preclinical Alzheimer's disease	21
GAPDH citrullination as a molecular signature of neurodegeneration, assessed in prion diseases	21
Boswellic Acids Improve Clinical Cognitive Scores and Reduce Systemic Inflammation in Patients with Mild to Moderate Alzheimer’s Disease	20
Landscape of Double-Stranded DNA Breaks in Postmortem Brains from Alzheimer’s Disease and Non-Demented Individuals	20
A Pilot Study of Near-Infrared Light Treatment for Alzheimer’s Disease	20

Classifying Alzheimer’s Disease Neuropathology Using Clinical and MRI Measurements	20
Validation of the Updated “LIfestyle for BRAin health” (LIBRA) Index in the English Longitudinal Study of Ageing and Maastricht Aging Study	20
The Impact of Misaligned Perceived and Objective Fall Risk in Cognitively Impaired Older People	20
Neuropsychiatric signs and symptoms clusters and regional amyloid on ¹⁸ F-FC119S PET in Alzheimer's disease	20
Reporting of comorbidities and health status of participants in clinical trials testing amyloid- and tau-targeting monoclonal antibodies for Alzheimer's disease: A systematic review	20
Association Between Statin Use and Dementia, and Related Mechanisms: A Bibliometric Analysis from 2007 to 2023	20
Ketogenic diet enhances cognitive-behavioral function and hippocampal neurogenesis while attenuating amyloid pathology in Tg-SwDI mice	20
Real-world experience with baseline characteristics and safety of lecanemab for Alzheimer's disease in Eastern China	20
Associations between neuropsychiatric symptoms and pathology in clinicopathologically defined Alzheimer's disease, Alzheimer's disease with Lewy bodies, and dementia with Lewy bodies	20
Meaning in life and neurobiomarkers of brain health in the UK Biobank	20
Helicobacter pylori and Alzheimer's disease risk: The HUNT study	20
Associations of Physical Activity Engagement with Cerebral Amyloid-β and Tau from Midlife	20
Alzheimer’s Disease Is a Multi-Organ Disorder: It May Already Be Preventable	20
COVID-19 and neurodegeneration: Perspectives on the impact of viruses on the brain	20
Improving Regression Analysis with Imputation in a Longitudinal Study of Alzheimer’s Disease	20
Periodontitis associated with multi-region brain functional alterations and cognitive impairment: A cross-sectional study in normal cognition, amnestic mild cognitive impairment, and Alzheimer's disea	20
Hyperglycemia Aggravates the Cerebral Ischemia Injury via Protein O-GlcNAcylation	20
The Brain Health Platform: Combining Resilience, Vulnerability, and Performance to Assess Brain Health and Risk of Alzheimer’s Disease and Related Disorders	19
Validation of the care partner stress scale in the CAN-PROTECT study	19
What Impact Does the Diagnosis of Mild Cognitive Impairment Have on the Wellbeing, Everyday Behavior, and Healthcare Utilization of People and Their Carers? A Systematic Review	19
A systematic review of lifestyle-based interventions for managing Alzheimer's disease: Insights from randomized controlled trials	19
Mild Cognitive Impairment, Reversion Rates, and Associated Factors: Comparison of Two Diagnostic Approaches	19
A nomogram including serum iron metabolism-related indicator and cerebral microbleeds for predicting vascular cognitive impairment in patients	19
Lipopolysaccharides from Porphyromonas gingivalis indirectly induce neuronal GSK3β-dependent synaptic defects and cause cognitive decline in a low-amyloi	19
Heterogeneity in the association between antihypertensive medications and Alzheimer's disease and related dementias risk: A multidimensional machine learning analysis to inform drug repurposing	19
Posttraumatic Stress and Traumatic Brain Injury: Cognition, Behavior, and Neuroimaging Markers in Vietnam Veterans	19
Effects of Sideritis scardica Extract on Scopolamine-Induced Learning and Memory Impairment in Mice	19
Societal Costs of Dementia: 204 Countries, 2000–2019	19
Integration of multi-omics and artificial intelligence for therapeutic insights in Alzheimer's disease: A comprehensive review	19
Identification and cognitive function prediction of Alzheimer's disease based on multivariate pattern analysis of hippocampal volumes	19
Effects of Type 2 Diabetes on the Neuropsychological Profile in Mild Cognitive Impairment	19
Effects of Intermittent Hypoxia Protocols on Cognitive Performance and Brain Health in Older Adults Across Cognitive States: A Systematic Literature Review	19
Effect and Mechanism of Rapamycin on Cognitive Deficits in Animal Models of Alzheimer’s Disease: A Systematic Review and Meta-analysis of Preclinical Studies	19
Plasma p-tau217 measured by the Elecsys automated immunoassay: Prospective validation in a heterogeneous memory clinic cohort	19
Aging in place preferences of older adults with cognitive impairment and informal caregivers: A qualitative analysis of a discrete choice experiment	19
Gait and movement analysis for discrimination between people with dementia and healthy control persons based on pose estimation and machine learning	19
Brain 11β-Hydroxysteroid Dehydrogenase Type 1 Occupancy by Xanamem™ Assessed by PET in Alzheimer’s Disease and Cognitively Normal Individuals	19
Hearing loss, plasma neurodegenerative biomarkers, and cognitive function: Independent and additive effects	19
Projecting the Likely Impact of COVID-19 Infections on the Prevalence of Dementia in the United States	18
Explore the Role of Frailty as a Contributor to the Association Between AT(N) Profiles and Cognition in Alzheimer’s Disease	18
Association between lipid levels and dementia risk among older Ghanaian adults	18
Nicotinamide mononucleotide supplementation modulates gut microbiota and metabolites to mitigate Alzheimer's disease pathology in APP/PS1 mice	18
The Dual Role of Astrocyte-Derived Exosomes and Their Contents in the Process of Alzheimer’s Disease	18
Vaccines and Dementia: Part I. Non-Specific Immune Boosting with BCG: History, Ligands, and Receptors	18
The relationship between plasma oxidized low-density lipoprotein and all-cause cognitive impairment: A population-based cross-sectional study in a rural area of Xi’an, China	18
Protocol for a Mixed-Methods Process Evaluation of BetterBrains: A Person-Centered Online Intervention to Delay Cognitive Decline in Adults at Risk of Dementia	18
Fear of Falling as a Behavioral Symptom in Neurocognitive Impaired Patients: Evidence from an Underrepresented Population	18
The relationship between postoperative cognitive dysfunction and cerebral small vessel disease: A comprehensive review	18
Identifying Comorbidity Patterns in People with and without Alzheimer’s Disease Using Latent Dirichlet Allocation	18
Amyloid-related imaging abnormalities after immunotherapy: How might brain microvascular basement membrane components be involved?	18
Testing a Polygenic Risk Score for Morphological Microglial Activation in Alzheimer’s Disease and Aging	18
Amyloid-Negative, Neurodegeneration-Negative Amnestic Mild Cognitive Impairment	18
A Machine Learning Approach for Early Diagnosis of Cognitive Impairment Using Population-Based Data	18
Hearing loss and the risk of dementia: A longitudinal analysis of the Korean National Health Insurance Service Senior Cohort	18
Including General Audiences in a Virtual Scientific Dementia Conference: Will They Get Anything From It?	18
Biomarkers and Mindfulness: A Way Forward	18
The Association Between Cognition of Obstructive Sleep Apnea Patients and Urinary AD7c-NTP Level: Investigation and Application	18
Development and Characterization of Mouse-Specific Anti-Tau Monoclonal Antibodies: Relevance for Analysis of Murine Tau in Cerebrospinal Fluid	18
Incretin Mimetics as Potential Disease Modifying Treatment for Alzheimer’s Disease	18
Brain-derived neurotrophic factor and its relationship to known biomarkers of Alzheimer's disease	18
Mutual effects of sleep duration and traits on the risk of dementia: A prospective study in the UK Biobank	18
Gamma Frequency Inhibits the Secretion and Aggregation of Amyloid-β and Decreases the Phosphorylation of mTOR and Tau Proteins in vitro	18
Potentially Inappropriate Medication Use in Community-Dwelling Older Adults Living with Dementia	18
Down syndrome and Alzheimer's disease: Oxidative stress in the neurodegenerative process	18
PROTEIMERs as catalytic inhibitors of APP mRNA translation: Toward a new therapeutic for Alzheimer's disease	18
Do They Align? Congruence Between Patient Preferences of People Living with Cognitive Impairments and Physicians’ Judgements for Person-Centered Care: An Analytic Hierarchy Process Study	18
The importance of non-pharmacological interventions to improve cognitive reserve prior to the administration of a drug against the causative agent of Alzheimer's disease	17
Corrigendum to “The relationship between plasma oxidized low-density lipoprotein and all-cause cognitive impairment: A population-based cross-sectional study in a rural area of Xi’an, China”	17
Effect of ceftriaxone on the glutamate-glutamine cycle and seizure susceptibility of Tg2576 mouse model of Alzheimer's disease	17
Repetitive transcranial magnetic stimulation enhances alpha power in Alzheimer's disease patients	17
Prognostic Information on Progression to Dementia: Quantification of the Impact on Quality of Life	17
Association of Age with Dual-Task Objective Cognitive Indicators and Gait Parameters in Older Adults	17
Impaired Skeletal Development by Disruption of Presenilin-1 in Pigs and Generation of Novel Pig Models for Alzheimer’s Disease	17
Double product is longitudinally associated with reduced cognitive function in type 2 diabetes with insights from cross-lagged panel analysis and mediation by leucine-rich α-2-glycoprotein 1	17
Sex differences in cognitive trajectories and practice effects in a cohort of older Londoners: The role of risk factors	17
Integrating network pharmacology and component analysis to investigate the potential mechanisms of Sheng-Hui-Yi-Zhi decoction in the treatment of Alzheimer’s disease	17
A Mini-Mental State Examination Formula May Help to Distinguish Alzheimer’s Disease from Dementia with Lewy Bodies	17
An Alzheimer’s Disease Mechanism Based on Early Pathology, Anatomy, Vascular-Induced Flow, and Migration of Maximum Flow Stress Energy Location with Increasing Vascular Disease	17
Alzheimer-typical temporo-parietal atrophy and hypoperfusion are associated with a more significant cholinergic impairment in amnestic neurodegenerative syndromes	17
Patterns of Limitation in Physical Function in Late Midlife Associated with Late-Onset Alzheimer’s Disease and Related Dementias: A Cluster Analysis	17
A 14-Year Longitudinal Analysis of Healthcare Expenditure on Dementia and Related Factors (DEMENCOST Study)	17
Causal Association Between mTOR-Dependent Protein Levels and Alzheimer’s Disease: A Mendelian Randomization Study	17
Concerning the debate about homocysteine, B vitamins, and dementia	17
Written picture descriptions distinguish variants of primary progressive aphasia	17
Exploring the Association Between Opioid Use Disorder and Alzheimer’s Disease and Dementia Among a National Sample of the U.S. Population	17
Agent Orange Herbicidal Toxin-Initiation of Alzheimer-Type Neurodegeneration	17
Identification of Major Cognitive Disorders in Self-Reported versus Administrative Health Data: A Cohort Study in Quebec	17
Scavenging Reactive Oxygen Species Decreases Amyloid-β Levels via Activation of PI3K/Akt/GLUT1 Pathway in N2a/APP695swe Cells	17
Exploring toxicity and mechanisms of DDTs in Alzheimer's disease through network toxicology and molecular docking insights	17
Structural white matter connectivity differences independent of gray matter loss in mild cognitive impairment with neuropsychiatric symptoms: Early indicators of Alzheimer's disease using network-base	17
miRNAs and Stem Cells as Promising Diagnostic and Therapeutic Targets for Alzheimer’s Disease	17
Loneliness, Dementia Status, and Their Association with All-Cause Mortality Among Older US Adults	17
Characterization of Apathy-Like Behaviors in Mouse Models of Down Syndrome	17
The role of built and social environments in Alzheimer's disease dementia prevalence in the United States: A machine learning approach	17
How much can biomarkers explain sociodemographic inequalities in cognitive dysfunction and cognitive impairment? Results from a machine learning model in the Health and Retirement Study	17